Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert John Wilkinson

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Lancet. Respiratory Medicine|February 8, 2014
Host-directed therapies against tuberculosisRobert John Wilkinson
The Journal of Infectious Diseases|January 7, 2012
Human genetic susceptibility to tuberculosis: time for a bottom-up approach?Robert John Wilkinson
Genome Biology|November 25, 2014
The road to drug resistance in Mycobacterium tuberculosisAnastasia Koch, Robert John Wilkinson
European Journal of Immunology|March 12, 2015
Humoral immunity in tuberculosisAshley Jacobs, Robert John Wilkinson
American Journal of Respiratory and Critical Care Medicine|April 23, 2009
Vitamin d and tuberculosis: new light on a potent biologic therapy?Robert John Wilkinson, Christoph Lange
Clinical Medicine (London, England)|December 5, 2015
Understanding and intervening in HIV-associated tuberculosisNeesha Rockwood, Robert John Wilkinson
Lancet (London, England)|April 16, 2011
Isoniazid preventive therapy in HIV infectionLori Elizabeth Dodd, Robert John Wilkinson
Microbiology Spectrum|January 14, 2017
The Immune Interaction between HIV-1 Infection and Mycobacterium tuberculosisElsa Du Bruyn, Robert John Wilkinson
The Lancet. Infectious Diseases|November 9, 2012
Diagnosis of paediatric tuberculosis: the culture conundrumLori Elizabeth Dodd, Robert John Wilkinson
The Lancet. Infectious Diseases|August 20, 2013
Isoniazid prevention of HIV-associated tuberculosisMolebogeng Xheedha Rangaka, Robert John Wilkinson
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Lancet. Respiratory Medicine|February 8, 2014
Host-directed therapies against tuberculosisRobert John Wilkinson
The Journal of Infectious Diseases|January 7, 2012
Human genetic susceptibility to tuberculosis: time for a bottom-up approach?Robert John Wilkinson
Genome Biology|November 25, 2014
The road to drug resistance in Mycobacterium tuberculosisAnastasia Koch, Robert John Wilkinson
European Journal of Immunology|March 12, 2015
Humoral immunity in tuberculosisAshley Jacobs, Robert John Wilkinson
American Journal of Respiratory and Critical Care Medicine|April 23, 2009
Vitamin d and tuberculosis: new light on a potent biologic therapy?Robert John Wilkinson, Christoph Lange
Clinical Medicine (London, England)|December 5, 2015
Understanding and intervening in HIV-associated tuberculosisNeesha Rockwood, Robert John Wilkinson
Lancet (London, England)|April 16, 2011
Isoniazid preventive therapy in HIV infectionLori Elizabeth Dodd, Robert John Wilkinson
Microbiology Spectrum|January 14, 2017
The Immune Interaction between HIV-1 Infection and Mycobacterium tuberculosisElsa Du Bruyn, Robert John Wilkinson
The Lancet. Infectious Diseases|November 9, 2012
Diagnosis of paediatric tuberculosis: the culture conundrumLori Elizabeth Dodd, Robert John Wilkinson
The Lancet. Infectious Diseases|August 20, 2013
Isoniazid prevention of HIV-associated tuberculosisMolebogeng Xheedha Rangaka, Robert John Wilkinson
Pageof 2